Trupanion Inc (NYSE:TRUP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. The brokerage presently has a $19.00 price objective on the stock. Zacks Investment Research’s target price indicates a potential upside of 12.49% from the stock’s previous close.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

TRUP has been the subject of a number of other reports. RBC Capital Markets reissued an “outperform” rating and set a $18.00 target price (up from $14.00) on shares of Trupanion in a research note on Wednesday, August 3rd. Canaccord Genuity reissued a “buy” rating and set a $19.00 target price on shares of Trupanion in a research note on Thursday, August 4th. Finally, Stifel Nicolaus boosted their target price on shares of Trupanion from $17.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, August 3rd. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $16.00.

Analyst Recommendations for Trupanion (NYSE:TRUP)

Trupanion (NYSE:TRUP) opened at 16.89 on Wednesday. The company has a 50 day moving average of $16.17 and a 200 day moving average of $15.21. Trupanion has a 52 week low of $7.61 and a 52 week high of $17.68. The company’s market capitalization is $494.08 million.

Trupanion (NYSE:TRUP) last posted its quarterly earnings data on Tuesday, November 1st. The company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The firm had revenue of $48.40 million for the quarter, compared to analysts’ expectations of $48.17 million. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.17) earnings per share. On average, equities analysts forecast that Trupanion will post ($0.23) EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Trupanion Inc (TRUP) Rating Increased to Buy at Zacks Investment Research” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright law. The legal version of this report can be read at https://www.thecerbatgem.com/2016/11/30/trupanion-inc-trup-rating-increased-to-buy-at-zacks-investment-research-2.html.

In related news, Director Howard E. Rubin sold 75,000 shares of the company’s stock in a transaction dated Monday, October 3rd. The shares were sold at an average price of $16.56, for a total value of $1,242,000.00. Following the completion of the sale, the director now directly owns 100,000 shares of the company’s stock, valued at $1,656,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Darryl Rawlings sold 3,500 shares of the company’s stock in a transaction dated Thursday, October 20th. The stock was sold at an average price of $16.15, for a total transaction of $56,525.00. Following the completion of the sale, the insider now directly owns 1,523,005 shares of the company’s stock, valued at $24,596,530.75. The disclosure for this sale can be found here.

A number of hedge funds have recently added to or reduced their stakes in TRUP. AQR Capital Management LLC purchased a new position in shares of Trupanion during the second quarter worth approximately $146,000. BlackRock Advisors LLC increased its position in shares of Trupanion by 88.0% in the third quarter. BlackRock Advisors LLC now owns 8,616 shares of the company’s stock worth $146,000 after buying an additional 4,032 shares in the last quarter. Metropolitan Life Insurance Co. NY purchased a new position in shares of Trupanion during the second quarter worth approximately $160,000. A.R.T. Advisors LLC purchased a new position in shares of Trupanion during the second quarter worth approximately $166,000. Finally, Alliancebernstein L.P. purchased a new position in shares of Trupanion during the second quarter worth approximately $168,000.

Trupanion Company Profile

Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.

5 Day Chart for NYSE:TRUP

Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.